CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+7.34%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$6.59B
AUM Growth
+$6.59B
(+12%)
Cap. Flow
+$266M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
67.98%
Holding
142
New
14
Increased
47
Reduced
57
Closed
13
Top Buys
| 1 |
Visa
V
|
$48M |
| 2 |
Microsoft
MSFT
|
$42.7M |
| 3 |
Thermo Fisher Scientific
TMO
|
$38.8M |
| 4 |
Ecolab
ECL
|
$37.9M |
| 5 |
FRC
First Republic Bank
FRC
|
$34.6M |
Top Sells
| 1 |
HDFC Bank
HDB
|
$105M |
| 2 |
Philip Morris
PM
|
$21.5M |
| 3 |
Meta Platforms (Facebook)
META
|
$11.6M |
| 4 |
CELG
Celgene Corp
CELG
|
$10.4M |
| 5 |
Merck
MRK
|
$8.98M |
Sector Composition
| 1 | Financials | 26.2% |
| 2 | Healthcare | 18.75% |
| 3 | Consumer Discretionary | 17.75% |
| 4 | Communication Services | 14.57% |
| 5 | Materials | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Teva Pharmaceuticals
TEVA
$21.4B
| $8.31M | 0.13% |
250,231
-22,819
| -8% | -$758K |
|
52
Viatris
VTRS
$12.3B
| $7.56M | 0.11% |
194,639
-19,152
| -9% | -$743K |
|
53
Exelixis
EXEL
$10B
| $7.27M | 0.11% |
295,175
-260,283
| -47% | -$6.41M |
|
|
TSRO
54
DELISTED
TESARO, Inc.
TSRO
| $6.54M | 0.1% |
46,732
-1,241
| -3% | -$174K |
|
55
Dynavax Technologies
DVAX
$1.19B
| $6.45M | 0.1% |
668,215
+384,133
| +135% | +$3.71M |
|
|
KITE
56
DELISTED
Kite Pharma, Inc.
KITE
| $6.06M | 0.09% |
58,443
-2,657
| -4% | -$275K |
|
57
Exact Sciences
EXAS
$9.25B
| $5.76M | 0.09% |
162,710
-28,444
| -15% | -$1.01M |
|
58
Cardinal Health
CAH
$35.9B
| $5.56M | 0.08% |
71,382
-23,931
| -25% | -$1.86M |
|
59
Insulet
PODD
$24.1B
| $5.49M | 0.08% |
107,065
+17,644
| +20% | +$905K |
|
|
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.43M | 0.08% |
96,590
-27,963
| -22% | -$1.57M |
|
|
AIMT
61
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $5.12M | 0.08% |
248,800
+60,700
| +32% | +$1.25M |
|
62
Ultragenyx Pharmaceutical
RARE
$3.07B
| $4.78M | 0.07% |
76,927
+18,257
| +31% | +$1.13M |
|
63
NovoCure
NVCR
$1.34B
| $4.73M | 0.07% |
+273,600
| New | +$4.73M |
|
|
AERI
64
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.71M | 0.07% |
89,549
+13,458
| +18% | +$707K |
|
|
HZNP
65
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.61M | 0.07% |
388,284
+57,575
| +17% | +$683K |
|
|
KTWO
66
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.47M | 0.07% |
183,577
+9,206
| +5% | +$224K |
|
67
DexCom
DXCM
$30.1B
| $4.47M | 0.07% |
61,095
+9,851
| +19% | +$721K |
|
|
XENT
68
DELISTED
Intersect ENT, Inc
XENT
| $4.14M | 0.06% |
147,998
-33,552
| -18% | -$938K |
|
69
Sarepta Therapeutics
SRPT
$1.94B
| $4.1M | 0.06% |
121,528
+38,793
| +47% | +$1.31M |
|
|
ESRX
70
DELISTED
Express Scripts Holding Company
ESRX
| $4.01M | 0.06% |
62,863
-6,632
| -10% | -$423K |
|
|
EGRX
71
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.85M | 0.06% |
48,741
-16,344
| -25% | -$1.29M |
|
72
Algonquin Power & Utilities
AQN
$4.35B
| $3.6M | 0.05% |
264,000
| – | – |
|
|
DERM
73
DELISTED
Dermira, Inc.
DERM
| $3.52M | 0.05% |
120,815
+38,069
| +46% | +$1.11M |
|
74
Puma Biotechnology
PBYI
$266M
| $3.48M | 0.05% |
39,834
+6,465
| +19% | +$565K |
|
75
Coherus Oncology, Inc. Common Stock
CHRS
$143M
| $3.47M | 0.05% |
241,505
+48,618
| +25% | +$698K |
|